Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 24: The SELECT Trial
Author(s): Subodh Verma Added: 5 months ago
AHA Conference 2024 - Outcomes of SELECT show that semaglutide treatment in obese or overweight patients with prior history of coronary artery bypass graft (CABG) surgery reduces the risk of cardiovascular events.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us onsite at AHA Conference to discuss the findings from SELECT (NCT03574597).SELECT is a randomized, double-blind, placebo… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ESC 24 Hot Line Discussion: The SWEDEGRAFT Trial
Author(s): Harriette Van Spall , Stefan James Added: 8 months ago
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).The SWEDEGRAFT trial is a prospective, binational, multicenter, open… View more

Vascular Disease and Surgery

Intervention
Bruce Rollman
Job title: Professor of Medicine, Psychiatry, and Clinical and Translational Science
Dr Bruce L Rollman's research focuses on interventions to improve the quality of care for patients with depression and anxiety who are care for in non-psychiatric settings. Dr Rollman was also Principal Investigator for the Bypassing the Blues Trial that demonstrated the effectiveness and cost-effectiveness of a nurse-led and telephone-delivered collaborative care strategy for treating depression… View more
CRT 24: SYNTAX: PCI With TAXUS and CABG in Complex Coronary Disease
Author(s): Patrick W Serruys Added: 1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary… View more

Vascular Disease and Surgery

Intervention
Research Area(s) / Expertise: Job title: Consultant Cardiologist, Bristol Heart Institute
Dr Johnson is fully trained in percutaneous coronary intervention and all aspects of general cardiology including hypertension, cardiovascular risk assessment, valvular heart disease, heart failure and arrhythmia. He qualified from St Mary's Hospital (Imperial College, London) in 1998 and prior to commencing specialist training in the South West he undertook a period of research studying novel… View more
Kendra J Grubb
Research Area(s) / Expertise: Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more
EuroPCR 23: FAME III Three-Year Follow-Up
Author(s): Frederik Zimmermann Added: 1 year ago
EuroPCR 23 – In this late-breaking science interview, we are joined by Prof Frederick Zimmermann (Catharina Hospital, NL) to discuss the findings from a 3-year follow-up of the FAME III trial. The objective of the FAME 3 trial was to demonstrate the noninferiority of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) compared to coronary artery bypass grafting (CABG)… View more

Vascular Disease and Surgery

Imaging & Diagnostics
View from the Thoraxcenter: ESC Congress 24 Hot Line Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 9 months ago
Which interventional cardiology studies will have the greatest impact at ESC 2024?Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated hot line studies set to be unveiled at ESC Congress 2024. Get their in-depth analysis of the studies and gain invaluable insights ahead of the curve.ESC Congress… View more

MI/ACS

Intervention
Author(s): Rasha Al-Lamee , Michael Foley Added: 1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and… View more

Prevention & Chronic Conditions
Job title: Consultant Cardiothoracic Surgeon, Guys and St.Thomas's Hospital, London, UK
Mr. Gianluca Lucchese is a consultant cardiothoracic surgeon in central London, specializing in minimally invasive cardiac surgery, valve repair and replacement, and complex aortic surgery. He is also an expert in transcatheter aortic valve implantation (TAVI), coronary artery bypass grafting, atrial fibrillation surgery, and grown-up congenital heart disease (GUCH). Mr. Lucchese treats private… View more